Also trades as: 092730.KS (KSC) · $vol 0M
092730.KQ KOE
NeoPharm Co. Ltd.
1W: -2.3%
1M: -4.9%
3M: +24.9%
YTD: +15.6%
1Y: +22.7%
3Y: +11.4%
5Y: -22.8%
₩23,100.00 ($17.20)
-200.00 (-0.86%)
Weekly Expected Move ±5.0%
₩20781
₩21940
₩23100
₩24260
₩25419
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$28.4B
+52.5% ▲
5Y CAGR: +10.7%
Capital Expenditures
$1.2B
+61.5% ▲
5Y CAGR: +8.4%
Free Cash Flow
$27.2B
+75.0% ▲
5Y CAGR: +10.8%
Dividends Paid
$9.4B
-60.0% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$8.6B
+35.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $17.7B | $17.0B | $23.2B | $23.1B | $27.8B |
| Depreciation & Amort. | $1.5B | $1.6B | $1.7B | $3.1B | $3.1B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $1.0B | -$1.4B | -$2.6B | -$7.3B | -$2.3B |
| Other Non-Cash Items | $1.4B | $908M | $950M | -$246M | -$185M |
| Operating Cash Flow | $21.7B | $18.2B | $23.3B | $18.6B | $28.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$478M | -$806M | -$20.8B | -$2.8B | -$1.4B |
| Acquisitions (Net) | $855K | $150K | $0 | $0 | $10M |
| Investment Purchases | -$114.0B | -$213.0B | -$186.6B | -$113.3B | -$127.8B |
| Investment Sales | $98.0B | $205.0B | $191.1B | $110.2B | $120.6B |
| Other Investing | -$210M | $7M | -$12M | -$289M | -$1.0B |
| Investing Cash Flow | -$16.7B | -$8.8B | -$16.4B | -$6.2B | -$9.6B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4.0B | -$495M | -$534M | -$598M | $0 |
| Stock Repurchased | $0 | $0 | $0 | -$36M | $0 |
| Dividends Paid | -$5.1B | -$5.5B | -$5.5B | -$5.9B | -$9.4B |
| Other Financing | -$436M | $219M | $92M | $5M | -$791M |
| Financing Cash Flow | -$9.5B | -$5.8B | -$5.9B | -$6.5B | -$10.2B |
| Net Change in Cash | -$4.1B | $3.8B | $998M | $6.4B | $8.6B |
| Cash End of Period | $7.0B | $10.9B | $11.9B | $18.2B | $26.8B |
| Free Cash Flow | $21.2B | $17.4B | $2.4B | $15.6B | $27.2B |